Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

LON/CTEC stock hub

LON/CTEC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/CTECis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/CTEC

In the news

Latest news · LON/CTEC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.1

P25 12.9P50 16.9P75 23.5

Trailing P/E32.1

P25 15.9P50 22.9P75 35.8

ROE10.9

P25 -54.2P50 2.1P75 13.7

ROIC10.5

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/CTEC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	10,910
Employees Change	421%
Employees Change Percent	4.01
Enterprise value	GBX 5.1B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	GB00BD3VFW73
Last refreshed	2026-05-10
Market cap	GBX 4B
Price	GBX 205
Price currency	GBX
Rev Per Employee	166,102.38x
Sector	Healthcare
Sic	3842
Symbol	lon/CTEC
Website	https://www.convatecgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.24%
EV Earnings	39.13x
EV/EBIT	16.7x
EV/EBITDA	11.17x
EV/FCF	20.44x
EV/Sales	2.81x
FCF yield	6.21%
Forward P/E	14.09x
P/B ratio	3.56x
P/E ratio	32.11x
P/S ratio	2.21x
PE Ratio10 Y	51.33x
PE Ratio3 Y	34.13x
PE Ratio5 Y	39.92x
PEG ratio	1.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.81%
EBITDA Margin	24.07%
FCF margin	13.74%
Gross margin	56.25%
Gross Profit	GBX 1B
Gross Profit Growth	3.83%
Gross Profit Growth Q	7.7%
Gross Profit Growth3 Y	3.64%
Gross Profit Growth5 Y	3.55%
Net Income	GBX 130M
Net Income Growth	-8.38%
Net Income Growth Q	-37.54%
Net Income Growth Years	0%
Net Income Growth3 Y	4.53%
Net Income Growth5 Y	20.01%
Pretax Margin	9.43%
Profit Margin	7.18%
Profit Per Employee	GBX 11,918
Profitable Years	9
ROA	7.02
Roa5y	5.25
ROCE	12.95
ROE	10.91
Roe5y	8.18
ROIC	10.51
Roic5y	8.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-18.24%
Cagr3y	0.96%
Cagr5y	-0.37%
Div CAGR3	1.97%
Div CAGR5	5.29%
EPS Growth	-7.53
EPS Growth Q	-36.5
EPS Growth Years	0
EPS Growth3 Y	5.14
EPS Growth5 Y	20.34
FCF Growth	9.84%
FCF Growth Q	-12.14%
FCF Growth3 Y	7.43%
FCF Growth5 Y	29.27%
OCF Growth	18.39%
OCF Growth Q	-2.63%
OCF Growth10 Y	1.64%
OCF Growth3 Y	7.48%
OCF Growth5 Y	15.21%
Revenue Growth	6.55x
Revenue Growth Q	7.1x
Revenue Growth Quarters	6x
Revenue Growth Years	6x
Revenue Growth3 Y	3.49x
Revenue Growth5 Y	3.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.67
Assets	GBX 2.8B
Cash	GBX 50.5M
Current Assets	GBX 689.5M
Current Liabilities	GBX 451.8M
Debt	GBX 1.1B
Debt EBITDA	GBX 2.48
Debt Equity	GBX 1
Debt FCF	GBX 4.53
Equity	GBX 1.1B
Interest Coverage	6.61
Liabilities	GBX 1.7B
Long Term Assets	GBX 2.1B
Long Term Liabilities	GBX 1.2B
Net Cash	GBX -1.1B
Net Cash By Market Cap	GBX -26.86
Net Debt EBITDA	GBX 2.47
Net Debt Equity	GBX 0.96
Net Debt FCF	GBX 4.33
Tangible Book Value	GBX -355.2M
Tangible Book Value Per Share	GBX -0.18
WACC	7.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.53
Inventory Turnover	2.79
Net Working Capital	GBX 209.5M
Quick ratio	0.76
Working Capital	GBX 240.7M
Working Capital Turnover	GBX 5.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.09%
Dividend Growth	6.15%
Dividend Growth Years	1%
Dividend per share	GBX 0.05
Dividend Years	10
Dividend Yield	2.59%
Ex Div Date	2026-04-16
Last Dividend	GBX 0.04
Payout Frequency	Semi-Annual
Payout Ratio	80%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-18.22%
200-day SMA	233.8
3Y total return	2.91%
50-day SMA	228.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-1.86%
All Time High	349.1
All Time High Change	-41.22%
All Time High Date	2017-06-05
All Time Low	113.3
All Time Low Change	81.19%
All Time Low Date	2019-02-14
ATR	6.55
Beta	0.78
Beta1y	1.13
Beta2y	0.75
Ch YTD	-15.63
High	209.4
High52	311.2
High52 Date	2025-06-05
High52ch	-34.06%
Low	203.6
Low52	203.6
Low52 Date	2026-05-08
Low52ch	0.59%
Ma50ch	-10.27%
Price vs 200-day SMA	-12.22%
RSI	33.89
RSI Monthly	42.05
RSI Weekly	38.35
Sharpe ratio	-0.68x
Sortino ratio	-0.76
Total Return	3.68%
Tr YTD	-14.21
Tr1m	-2.69%
Tr1w	-2.29%
Tr3m	-7.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 304.6M
Operating Income Growth	7.7
Operating Income Growth Q	14.02
Operating Income Growth3 Y	10.88
Operating Income Growth5 Y	8.57
Operating margin	16.81

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,946,152,801%
Net Borrowing	166,507,678
Shares Insiders	0.05%
Shares Institutions	90.88%
Shares Out	1,954,454,579
Shares Qo Q	-1.74%
Shares Yo Y	-1.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX 228.1M
Average Volume	8,087,314.25x
Bv Per Share	0.58
CAPEX	GBX -100.3M
Ch1m	-4.29
Ch1w	-2.29
Ch1y	-20.03
Ch3m	-9.04
Ch3y	-3.21
Ch5y	-11.55
Ch6m	-12.98
Change	-1.82%
Change From Open	-1.16
Close	209
Days Gap	-0.67
Depreciation Amortization	129,831,978
Dollar Volume	1,376,017,232.4
Earnings Date	2026-08-04
EBIT	GBX 304.6M
EBITDA	GBX 436.1M
EPS	GBX 0.06
F Score	6
FCF	GBX 248.9M
FCF EV Yield	4.89x
FCF Per Share	GBX 0.13
Financing CF	-191,694,000
Fiscal Year End	December
Founded	1,978
Goodwill	990,243,900
Graham Number	92.941
Graham Upside	-54.71
Income Tax	GBX 40.9M
Investing CF	-154,544,000
Is Primary Listing	1
Last Earnings Date	2026-02-24
Last Report Date	2025-12-31
Lynch Fair Value	GBX 133
Lynch Upside	-35.13
Ma150	233.7
Ma150ch	-12.19%
Ma20	223.5
Ma20ch	-8.19%
Net CF	2,229,000
Next Earnings Date	2026-08-04
Open	207.6
P FCF Ratio	16.11
P OCF Ratio	11.48
Payment Date	2026-05-28
Position In Range	27.59
Ppne	564,072,266
Price Date	2026-05-08
Price EBITDA	GBX 9.2
Relative Volume	0.82x
Revenue	1,812,177,000x
SBC By Revenue	1.15x
Share Based Comp	20,804,000
Tax By Revenue	2.26x
Tax Rate	23.91%
Tr6m	-11.52%
Volume	6,705,737
Z Score	2.57

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/CTEC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.6%

$0.05 annual per share

Payout ratio

+80.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.3%

1 consecutive years of growth

Total shareholder yield

+3.7%

Next ex-dividend date: 2026-04-16

Performance

LON/CTEC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/CTEC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.9%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.1%

Negative means the company is buying back shares.

Technical

LON/CTEC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.9

Neutral momentum band

Price vs 200-day MA

-12.2%

50/200-day relationship not available

Beta (5Y)

0.78

Less volatile than the market

Sharpe ratio

-0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/CTEC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/CTEC stock rating?

lon/CTEC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/CTEC analysis?

The full report lives at /stocks/lon/CTEC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/CTEC?

The latest report frames lon/CTEC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/CTEC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.